CA
NZ
UK
AU
IND
US
Single-Patient Case Study Highlights Early Signal for Phyto-N in Cancer CachexiaCuranex Pharmaceuticals drew market attention after presenting a single-patient case study suggesting potential symptomatic benefits of its lead candidate, Phyto-N, in cancer cachexia and advanced cancer supportive care. The patient, treated for a pancreatic …
BioXcel Therapeutics has initiated patient enrollment in a Phase 2a clinical trial evaluating BXCL501 for acute stress reactions (ASR), marking a notable step in the company’s effort to expand its neuroscience pipeline. The study, funded by the U.S. Department of War and led by …
AI Nose Healthcare Deployment Signals Strategic Expansion into High-Value InfrastructureAinos, Inc. (NASDAQ: AIMD) has announced a partnership with MacKay Memorial Hospital and Topco Scientific to deploy its AI Nose technology across critical hospital environments. This move marks a notable extension of its Smell AI …
PMGC Holdings’ full utilization of its $20 million equity purchase facility with Streeterville Capital marks a notable step in reinforcing its balance sheet. The transaction provides incremental liquidity to support near-term acquisitions and integration efforts, while signaling management’s intent to actively deploy capital across …
enGene Therapeutics Name Change Reflects Commercial Transition StrategyenGene’s decision to rebrand from enGene Holdings Inc. to enGene Therapeutics Inc. marks a strategic inflection point as the company moves closer to potential commercialization. The name change, effective April 8, 2026, aligns with its evolving identity …
Cryptocurrency markets have once again demonstrated their sensitivity to global macro developments. Bitcoin’s sharp rally following news of a temporary ceasefire between the United States and Iran highlights the asset class’s growing alignment with broader risk sentiment.
Global financial markets pivoted sharply toward a risk-on stance after a temporary ceasefire agreement between the United States and Iran signaled a pause in escalating geopolitical tensions. The development marks a critical inflection point after weeks of heightened uncertainty that had driven volatility across …
The electronic technology sector delivered one of its most synchronised advances in recent memory, with virtually every corner of the hardware supply chain posting robust gains as investors reconsidered the durability of artificial intelligence-driven capital expenditure and the prospects for a recovery in the …
The Trump administration's April 2, 2026 executive order on pharmaceutical tariffs is not primarily a trade instrument. It is a coercion mechanism. By invoking Section 232 of the Trade Expansion Act of 1962, the administration classified dependence on foreign-manufactured patented drugs as a national …
Brent crude plunged more than 15% toward $90 per barrel on Wednesday after President Donald Trump announced a conditional two-week ceasefire, delaying his threat to strike Iranian civilian infrastructure. WTI crude oil moved in near-lockstep, shedding comparable ground in one of the largest single-session …
Please wait processing your request...